---
title: "Regorafenib - Hepatocellular Carcinoma"
sidebar: mydoc_sidebar
permalink: db08896-mesh-d006528-1.html
toc: false 
---


Path ID: `DB08896_MESH_D006528_1`
{% include image.html url="images/db08896-mesh-d006528-1.png" file="db08896-mesh-d006528-1.png" alt="db08896-mesh-d006528-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:C559147">MESH:C559147 </a> | regorafenib | Disease |
| <a href="https://identifiers.org/UniProt:P04049">UniProt:P04049 </a> | RAF proto-oncogene serine/threonine-protein kinase | Protein |
| <a href="https://identifiers.org/UniProt:P15056">UniProt:P15056 </a> | Serine/threonine-protein kinase B-raf | Protein |
| <a href="https://identifiers.org/UniProt:P16234">UniProt:P16234 </a> | Platelet-derived growth factor receptor alpha | Protein |
| <a href="https://identifiers.org/UniProt:P11362">UniProt:P11362 </a> | Fibroblast growth factor receptor 1 | Protein |
| <a href="https://identifiers.org/UniProt:P17948">UniProt:P17948 </a> | Vascular endothelial growth factor receptor 1 | Protein |
| <a href="https://identifiers.org/UniProt:P35968">UniProt:P35968 </a> | Vascular endothelial growth factor receptor 2 | Protein |
| <a href="https://identifiers.org/reactome:R-HSA-9006934">reactome:R-HSA-9006934 </a> | Signaling by Receptor Tyrosine Kinases | Pathway |
| <a href="https://identifiers.org/GO:0008284">GO:0008284 </a> | positive regulation of cell population proliferation | BiologicalProcess |
| <a href="https://identifiers.org/GO:0045766">GO:0045766 </a> | positive regulation of angiogenesis | BiologicalProcess |
| <a href="https://identifiers.org/MESH:D006528">MESH:D006528 </a> | Hepatocellular Carcinoma | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Regorafenib | DECREASES ACTIVITY OF | Raf Proto-Oncogene Serine/Threonine-Protein Kinase |
| Regorafenib | DECREASES ACTIVITY OF | Serine/Threonine-Protein Kinase B-Raf |
| Regorafenib | DECREASES ACTIVITY OF | Platelet-Derived Growth Factor Receptor Alpha |
| Regorafenib | DECREASES ACTIVITY OF | Fibroblast Growth Factor Receptor 1 |
| Regorafenib | DECREASES ACTIVITY OF | Vascular Endothelial Growth Factor Receptor 1 |
| Regorafenib | DECREASES ACTIVITY OF | Vascular Endothelial Growth Factor Receptor 2 |
| Raf Proto-Oncogene Serine/Threonine-Protein Kinase | PARTICIPATES IN | Signaling By Receptor Tyrosine Kinases |
| Serine/Threonine-Protein Kinase B-Raf | PARTICIPATES IN | Signaling By Receptor Tyrosine Kinases |
| Platelet-Derived Growth Factor Receptor Alpha | PARTICIPATES IN | Signaling By Receptor Tyrosine Kinases |
| Fibroblast Growth Factor Receptor 1 | PARTICIPATES IN | Signaling By Receptor Tyrosine Kinases |
| Vascular Endothelial Growth Factor Receptor 1 | PARTICIPATES IN | Signaling By Receptor Tyrosine Kinases |
| Vascular Endothelial Growth Factor Receptor 2 | PARTICIPATES IN | Signaling By Receptor Tyrosine Kinases |
| Signaling By Receptor Tyrosine Kinases | CONTRIBUTES TO | Positive Regulation Of Cell Population Proliferation |
| Signaling By Receptor Tyrosine Kinases | CONTRIBUTES TO | Positive Regulation Of Angiogenesis |
| Positive Regulation Of Cell Population Proliferation | CAUSES | Hepatocellular Carcinoma |
| Positive Regulation Of Angiogenesis | CAUSES | Hepatocellular Carcinoma |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB08896](https://go.drugbank.com/drugs/DB08896)
  - [https://pubmed.ncbi.nlm.nih.gov/31954487/](https://pubmed.ncbi.nlm.nih.gov/31954487/)
